Back to results
US 5,728,380 AGranted
Priobiotic containing enterococcus faecium strain NCIMB 40371
AssigneeUnilever Patent Holdings B.V.
InventorsWilliam Dennis Allen, Margaret Anneli Linggood, Philip Porter
Life of this patent
Estimating the term…
Abstract
A strain of Enterococcus faecium, deposited as NCIMB 40371, has valuable probiotic properties and is particularly effective in alleviating symptoms of irritable bowel syndrome (IBS) in human patients. The strain can be used in the manufacture of human foodstuffs.
Claims19
An edible composition for treating gastrointestinal disorders comprising an effective amount of viable organisms of Enterococcus faecium strain NCIMB 40371 in a pharmaceutically acceptable carrier material.
Dependencies are inferred from the claim text.